Skip to main content
. 2023 Jun 30;12(7):941. doi: 10.3390/biology12070941
AAV Adeno-associated virus
AC Adenocarcinoma
ACTS Adoptive T-cell therapies
AHR Aryl hydrocarbon receptor
AIF Apoptosis inducible factor
AIM-2 Absent in melanoma-2
AMP Antimicrobial peptides
APC Antigen-presenting cell
BECs Basal epithelial cells
CAC Cervical adenocarcinoma
CAR-T cell Chimeric antigen receptor T cell
CC Cervical cancer
CECs Cervical epithelial cells
cGAMP Cyclic GMP-AMP
cGAS cGMP-AMP synthase
CIN Cervical intraepithelial neoplasia
CLR C-type lectin receptors
CMI Cell-mediated immunity
CTL Cytotoxic T lymphocyte
DNAM-1 DNAX accessory molecule-1
DGE Differential gene expression
FoxP3 Forkhead box protein P3
FRT Female reproductive tract
HIF Hypoxia-inducible factor
HR-HPV High-risk HPV
hTERT Human telomeres reverse transcriptase
ICIs Immune checkpoint inhibitors
IDO Indolamine dioxygenase
LCs Langerhans cells
MAIT Mucosal-associated invariant T
MIP Macrophage inflammatory protein
MUC Mucin
NET Neutrophil extracellular trap
NKCC NK-cell-mediated toxicity
NKG2D Natural killer group 2D
NLR Neutrophil lymphocyte ratio
NOD Nucleotide-binding oligomerization domain
PRR Pattern-recognition receptor
RGS Regulator of G protein signaling
RICK RIP-like interacting CLARP kinase
SCC Squamous cell carcinoma
SIL Squamous intraepithelial lesion
STING Stimulating interferon genes
TCR T-cell receptor
TCR-T cells TCR-engineered/modified effector T cells
TDO Tryptophan dioxygenase
TIME Tumor immune microenvironment
TME Tumor microenvironment
TGF-β Transforming growth factor beta
TSLP Thymic stromal lymphopoietin
TZ Transformational Zone
VISTA V-domain immunoglobulin suppressor of T cell activation